Nuveen Asset Management
GRNA

Nuveen Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Nuveen Asset Management’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-104,610
Closed -$45K – 3335
2023
Q1 		$45K Hold
104,610
– – ﹤0.01% 3085
2022
Q4 		$123K Sell
104,610
-50,620
-33% -$59.5K ﹤0.01% 3093
2022
Q3 		$360K Buy
155,230
+135,718
+696% +$315K ﹤0.01% 3021
2022
Q2 		$43K Buy
+19,512
New +$43K ﹤0.01% 3213